Photo: AP

Moderna on Monday announced its experimental vaccine against Covid-19 was shown to be 94.5 percent effective according to early results from a clinical trial with more than 30,000 participants.

"This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease," said Stephane Bancel, Moderna's CEO.